Glycémie And NotP. Z. Zimmet
List of bibliographic references
Number of relevant bibliographic references: 7.Ident. | Authors (with country if any) | Title |
---|---|---|
000277 | Danielle A. J. M. Schoenaker [Australie, France] ; Dominique Simon [France] ; Nish Chaturvedi [Royaume-Uni] ; John H. Fuller [Royaume-Uni] ; Sabita S. Soedamah-Muthu [Pays-Bas] | Glycemic Control and All-Cause Mortality Risk in Type 1 Diabetes Patients: The EURODIAB Prospective Complications Study |
001855 | M. R. Skilton [Australie] ; C. Lange [France] ; O. Lantieri [France] ; B. Balkau [Australie, France] ; F. Bonnet [France] | Number of children and change in markers of metabolic health over 9-years in men and women. Data from the DESIR study |
001A56 | Stephen Colagiuri [Australie] ; Crystal M. Y. Lee [Australie] ; Tien Y. Wong [Australie, Singapour] ; Beverley Balkau [France] ; Jonathan E. Shaw [Australie] ; Knut Borch-Johnsen [Danemark] | Glycemic Thresholds for Diabetes-Specific Retinopathy: Implications for diagnostic criteria for diabetes |
002A27 | M. Marre [France] ; J. Shaw [Australie] ; M. Br Ndle [Suisse] ; W. M. W. Bebakar [Malaisie] ; N. A. Kamaruddin [Malaisie] ; J. Strand [Finlande] ; M. Zdravkovic [Danemark] ; T. D. Le Thi [Danemark] ; S. Colagiuri [Australie] | Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU) |
002C37 | Sophia Zoungas [Australie] ; Bastiaan E. De Galan [Australie, Pays-Bas] ; Toshiharu Ninomiya [Australie] ; Diederick Grobbee [Pays-Bas] ; Pavel Hamet [Canada] ; Simon Heller [Royaume-Uni] ; Stephen Macmahon [Australie] ; Michel Marre [France] ; Bruce Neal [Australie] ; Anushka Patel [Australie] ; Mark Woodward [Australie, États-Unis] ; John Chalmers [Australie] | Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: New results from the ADVANCE trial |
003277 | C. Lloret-Linares [France] ; J. R. Greenfield [Australie] ; S. Czernichow [France] | Effect of weight-reducing agents on glycaemic parameters and progression to Type 2 diabetes : a review |
004B04 | Philip Home [Royaume-Uni] ; Paul Bartley [Australie] ; David Russell-Jones [Royaume-Uni] ; Hélène Hanaire-Broutin [France] ; Jan-Evert Heeg [Pays-Bas] ; Pascale Abrams [Belgique] ; Mona Landin-Olsson [Suède] ; Birgitte Hylleberg [Danemark] ; Hanne Lang [Danemark] ; Eberhard Draeger [Danemark] | Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes a randomized clinical trial |
This area was generated with Dilib version V0.6.33. |